Safety and Efficacy of DNK333 in Atopic Dermatitis Patients

Clinical trial NCT01033097 · COMPLETED

Trial details

NCT number: NCT01033097
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pruritus in Patients With Atopic Dermatitis

Start date: 2009-11-01
Primary completion: 2011-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.